Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117024499A reveals a high-yield steroid synthesis method. This report analyzes cost reduction in steroid manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN114436877A details a novel Sacubitril synthesis avoiding high-risk oxidation. Achieve cost reduction in cardiovascular drug manufacturing with scalable routes.
Patent CN118812627A reveals advanced MMAE purification enhancing purity and yield for scalable ADC payload manufacturing supply chains and cost efficiency.
Patent CN110028407B details a novel rare earth catalyzed one-pot synthesis for spiro cyclopropane indene diketones, offering high stereoselectivity and cost-effective manufacturing for global supply chains.
Patent CN103896809A details a safer synthesis route for nafamostat mesylate intermediates. This method eliminates toxic cyanides and simplifies industrial scale-up for reliable supply chains.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN103189383B details novel biaryl diphosphine ligands enabling cost reduction in pharmaceutical intermediates manufacturing through improved asymmetric catalysis and scalability.
Novel halogenation method for Relugolix synthesis improves yield to 67.4% and purity to 99%, offering cost reduction in pharmaceutical manufacturing.
Patent CN101130499B details a mild SeO2-catalyzed reduction of dinitro compounds. This method offers high selectivity and cost advantages for pharmaceutical intermediate manufacturing.
Patent CN103483237B reveals green ionic liquid catalysis for pyrrole derivatives. Enhances supply chain reliability and reduces environmental impact significantly.
Patent CN101357903B details a novel extraction method for 4-formylaminoantipyrine, significantly improving purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN103739535B reveals solvent-free grinding synthesis. Offers high purity intermediates for pharma. Reduces environmental impact and supply chain risks significantly.
Patent CN1046530C details a novel sulfonation method reducing oxides. This ensures high purity ligand supply for catalysis with significant cost and efficiency advantages for global buyers.
Patent CN115819260B reveals a novel synthesis route for sitagliptin intermediates offering cost reduction and high purity for pharmaceutical supply chains.
Patent CN117924125B details metal-free visible light synthesis for sulfonamide derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel synthesis patent CN104447547B offers high yield 4-aminoisoquinoline-8-methyl formate. Reliable pharmaceutical intermediate supplier ensuring cost reduction and supply continuity.
Patent CN110684989B reveals a room-temperature electrochemical route for phenanthridine derivatives, offering significant cost reduction and safer manufacturing for pharmaceutical intermediates.
Novel catalytic method for benzoxy compounds ensures high purity and yield. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN108101863B reveals a novel route using carbonyl sulfide and disulfides. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113582982B reveals a novel chiral resolution and coupling route for Aprepitant, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.